Workflow
与深圳特区“双向奔赴” 华大基因持续用科技实力赋能民生健康

Core Insights - Shenzhen, as a pioneering city in China's reform and opening-up, has transformed from an agricultural county to one of the most open and economically vibrant cities in China, celebrating its 45th anniversary [1] - BGI Genomics (华大基因) emphasizes its commitment to "benefiting humanity through genetic technology" and its continuous innovation and empowerment in the life sciences industry, aligning its growth with Shenzhen's development [1][2] Company Development - BGI Genomics, founded in 1999, has established a strong presence in Shenzhen, benefiting from the city's innovative environment and government support, which includes tax reductions and on-site assistance from government officials [2] - The company has built a global marketing and service network covering over 100 countries and regions, becoming a leading provider of scientific and technological services and precision medical services [4] Technological Innovation - BGI Genomics has gained recognition for its contributions to significant projects, including the Human Genome Project in China and the decoding of the SARS virus genome, establishing itself as a leading genomics research institution [5] - The company focuses on continuous investment in upstream experimental technologies and applications in various fields, including molecular detection, reproductive health, cancer prevention, and infectious disease control [6] Global Strategy - BGI Genomics aims to leverage its experience in precision medicine and public health to promote Chinese technology and standards globally, enhancing local healthcare services and contributing to a more comprehensive health industry ecosystem [3] - The company plans to accelerate its global business layout, expand gene health screening applications, and integrate artificial intelligence with multi-omics data to enhance precision health management and medical services [6][7] Future Outlook - BGI Genomics is committed to transforming into a data-driven enterprise focused on disease prevention and health management, with the goal of becoming a leader in the precision medical and public health sectors [6][7]